ArticleJournal of translational medicine2025

Ivabradine induces RAD51 degradation, potentiating PARP inhibitor efficacy in non-germline BRCA pathogenic variant triple-negative breast cancer.

Ho Tsoi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.